DiscoverLifeSci Partners PodcastLeveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry
Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry

Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry

Update: 2023-10-03
Share

Description

Tune into Episode #2 of the LifeSci Search podcast with Andy Cronin (President & Co-Founder) and Ayesha Price (Sr. Director, Executive Search) as they host Iris Grossman (Chief Therapeutics Officer, Eleven Therapeutics) and Shahram Ebadollahi (Operating Partner, ARCHIMED & Former Chief Data Officer, Novartis) on the topic of AI and ML tools in Drug R&D. We get insights on how the tech is being leveraged in biotech and pharma along the R&D process, overall impact so far, thinking around AI and ML among leadership teams & boards, and perspectives on the competition for AI and ML talent within Life Sciences industry.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry

Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry

LifeSci Partners.com